Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brown, R. M.
Right arrow Articles by Brown, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, R. M.
Right arrow Articles by Brown, G. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 1361-1367, Copyright © 1997 by Oxford University Press

ARTICLES

Transfection screening for primary defects in the pyruvate dehydrogenase E1alpha subunit gene

RM Brown, LJ Otero and GK Brown
Department of Biochemistry, University of Oxford, UK.

In a significant number of patients with biochemical evidence of a defect in the E1 (pyruvate dehydrogenase) component of the pyruvate dehydrogenase complex, it has not proved possible to identify a mutation in the gene coding regions. To assess the need for more extensive genetic analysis in these patients and to establish a test system in which to study the biochemical consequences of mutations in the E1alpha subunit gene (which is responsible for the great majority of defined cases of pyruvate dehydrogenase deficiency), we have developed a method to screen for E1alpha gene defects based on complementation of the enzyme deficiency in transformed fibroblast cell lines following transfection and expression of the normal cDNA. Using this system, cell lines from patients with a variety of different defined mutations in the E1alpha gene show restoration of enzyme activity. A number of patients have been identified in whom deficient enzyme activity is not restored by expression of the normal cDNA indicating that an alternative explanation for the enzyme defect must be sought.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
M. R. Taylor, J. B. Hurley, H. A. Van Epps, and S. E. Brockerhoff
A zebrafish model for pyruvate dehydrogenase deficiency: Rescue of neurological dysfunction and embryonic lethality using a ketogenic diet
PNAS, March 30, 2004; 101(13): 4584 - 4589.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Y. Lib, R. M. Brown, G. K. Brown, M. F. Marusich, and R. A. Capaldi
Detection of Pyruvate Dehydrogenase E1{alpha}-subunit Deficiencies in Females by Immunohistochemical Demonstration of Mosaicism in Cultured Fibroblasts
J. Histochem. Cytochem., July 1, 2002; 50(7): 877 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Seyda, G. McEachern, R. Haas, and B. H. Robinson
Sequential deletion of C-terminal amino acids of the E1{alpha} component of the pyruvate dehydrogenase (PDH) complex leads to reduced steady-state levels of functional E1{alpha}2{beta}2 tetramers: implications for patients with PDH deficiency
Hum. Mol. Genet., April 12, 2000; 9(7): 1041 - 1048.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.